Word: kandel
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...appropriate future occasion,” said a Harvard spokesman, who added that the senator had originally been slated to attend the event. Also receiving degrees will be spiritual leader, the Aga Khan; Yale developmental psychologist James P. Comer; Princeton art historian Wen C; Fong, Columbia neuroscientist Eric R. Kandel; federal judge Damon J. Keith, women’s historian Gerda Lerner, Stanford computer scientist John McCarthy, University of Chicago biologist Janet D. Rowley, author and commencement speaker J. K. Rowling, and former Harvard Medical School Dean Daniel C. Tosteson...
Also receiving degrees will be spiritual leader Karim Aga Khan ’58; Yale developmental psychologist James P. Comer; Princeton art historian Wen C. Fong; Columbia neuroscientist Eric R. Kandel ’52; federal judge Damon J. Keith, women’s historian Gerda Lerner, Stanford computer scientist John McCarthy, University of Chicago biologist Janet D. Rowley, author J. K. Rowling, and former Harvard Medical School Dean Daniel C. Tosteson...
Including Kennedy, at least four of this year’s 11 honorary degree recipients boasted strong Harvard ties. Kandel, famous for his study of the brain, was a history and literature major as a Harvard undergraduate but found himself interested in discovering more about the brain after an encounter with a fellow student at the College whose parents were psychoanalysts, according to a biography posted by the Howard Hughes Medical Institute, where he serves as an investigator...
...science concentrator in this class. The material is very biological, so those with a biological background have a huge advantage over the Cognitive Psychology, Computer Science, Linguistics, and Philosophy concentrators required to take the course because they're in the Mind, Brain, and Behavior track. The Kandel textbook, written for upper level courses, is dense and chock-full of arcane jargon—don't bother buying...
...different approach to Alzheimer's is being pursued at Memory Pharmaceuticals. Drawing on Nobel-prizewinning research by co-founder Eric Kandel, the company hopes to develop drugs that reverse dementia, memory loss, depression and schizophrenia. Chief executive Tony Scullion says it has already developed a drug that fights Alzheimer's by restoring the process by which short-term memories are logged in for long-term recall. Swiss drug firm Roche is now testing it on humans, with clinical results expected in the near future...